Ziyad Al-Aly receives funding from U.S. Department of Veterans Affairs. A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn't use a patch. He ...

Taking a new generation of weight-loss medication is linked to a significantly lower risk of addiction and death from drugs such as cocaine and alcohol, a large US study suggested on Thursday. The ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Gina Roberts used to have this recurring nightmare: frantic and broke, she would search everywhere for a drink, but always the alcohol would remain out of reach. The dream would trigger such ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Ziyad Al-Aly, Washington University in St. Louis (THE CONVERSATION) A patient of mine, ...

New research has lent weight to the intriguing idea that GLP-1 agonists may have a role to play in helping people with substance use disorders (SUD) break their addiction. A meta-analysis carried out ...

First-person stories of drug addiction, hope, healing, and recovery. Addiction is a complex and often misunderstood condition. This gripping special provides raw, unfiltered access to first-person ...

Shalini Arunogiri receives funding from the National Health and Medical Research Council. She has received speaker honoraria from Camurus and Indivior, and advisory board fees from Indivior and Eli ...

Harvard economist Roland Fryer draws on a deeply personal experience to examine what economics reveals about drugs, addiction, and the laws meant to contain them. Photo: Free to Choose Network Cartel ...

Evidence continues to mount suggesting that GLP-1 drugs may help people cut back on cigarettes, drinking and opioid use. As the medications — which include semaglutide and tirzepatide — have grown in ...